Navigation Links
DURECT Corporation Announces Third Quarter 2013 Financial Results and Update of Programs
Date:11/4/2013

leading existing long acting products on the market and incorporates our ORADUR anti-tampering technology. Our licensee, Orient Pharma, is planning to meet with the Taiwan Food and Drug Administration (TFDA) later this year to discuss the Phase 3 program in that market and is developing its plans for further development in the defined Asian and South Pacific countries to which it has rights from us. We retain rights to all other markets in the world, notably including the U.S., Europe and Japan, and has initiated licensing discussions with other companies now that the lead formulation has been selected.
  • Relday™ (Risperidone Program). In January 2013, Zogenix (our licensee) announced positive single-dose pharmacokinetic (PK) results from a Phase 1 clinical trial of Relday. According to Zogenix, adverse events in the Phase 1 trial in patients diagnosed with schizophrenia were generally mild to moderate and consistent with other risperidone products. The Phase 1 clinical trial for Relday was conducted as a single-center, open-label, safety and PK trial of 30 patients with chronic, stable schizophrenia or schizoaffective disorder. Per Zogenix, based on the favorable safety and PK profile demonstrated with the 25 mg and 50 mg once-monthly doses tested in the Phase 1 trial, Zogenix extended the study to include a 100 mg dose of the same formulation. In May 2013, Zogenix announced positive results with the 100 mg arm, demonstrating dose proportionality across the full dose range that would be anticipated to be used in clinical practice. According to Zogenix, the positive results from this study extension positions Zogenix to begin a multi-dose clinical trial, which would provide the required steady-state pharmacokinetic and safety data prior to initiating Phase 3 development studies, subject to Zogenix's ability to secure a development and commercialization partner prior to initiation of the multi-dose trial.
    Relday is a proprietary, lo
    '/>"/>

  • SOURCE DURECT Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. DURECT Corporation Invites You to Join its Third Quarter 2013 Earnings Conference Call
    2. DURECT Announces Changes to its Board of Directors
    3. DURECT Corporation Announces Second Quarter 2013 Financial Results and Update of Programs
    4. DURECT Corporation Announces First Quarter 2013 Financial Results and Update of Programs
    5. DURECT Corporation Invites You to Join its First Quarter 2013 Earnings Conference Call
    6. DURECT Corporation Invites You to Join its Fourth Quarter 2012 Earnings Conference Call
    7. DURECT Corporation Announces Third Quarter 2012 Financial Results and Update of Programs
    8. DURECT Corporation Invites You to Join its Third Quarter 2012 Earnings Conference Call
    9. DURECT to Participate in Upcoming Healthcare Conferences
    10. DURECT Corporation Announces Second Quarter 2012 Financial Results and Update of Programs
    11. DURECT Corporation Announces First Quarter 2012 Financial Results and Update of Programs
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/29/2015)... The Judicial Panel on Multidistrict Litigation (JPML) ... centralize Inferior vena cava (IVC) Filter lawsuits filed against ... have already been centralized by the JPML. ... risk for a pulmonary embolism. The filters are designed ... Claims against Bard and Cook involve incidents of retrievable ...
    (Date:7/29/2015)... 2015 /PRNewswire/-- LabStyle Innovations Corp. (DRIO), today announced that its ... news segment in Australia .  The Dario ... regulatory and reimbursement approval in that country. ... living with diabetes. As a case in point, the news ... a 13 year old boy with Type 1 diabetes and ...
    (Date:7/29/2015)... FRANCISCO, Calif. , July 29, 2015 ... antibody company focused on developing innovative therapies to benefit ... focus on oncology, announced today that it received a ... ("NASDAQ") notifying the company that it is now compliant ... on the NASDAQ Global Market and is no longer ...
    Breaking Medicine Technology:IVC filter litigation continues; law firm provides free information to IVC filter patients 2LabStyle Innovations' Dario Diabetes Management Solution Featured on 9 News Australia 2LabStyle Innovations' Dario Diabetes Management Solution Featured on 9 News Australia 3KaloBios Regains Compliance with NASDAQ Minimum Bid Price Requirement 2KaloBios Regains Compliance with NASDAQ Minimum Bid Price Requirement 3KaloBios Regains Compliance with NASDAQ Minimum Bid Price Requirement 4
    ... cancer patients, who have an increased risk of developing venous thromboembolism ... an enhanced risk model to predict their chance of developing blood ... Blood , the journal of the American Society of Hematology. ... up to 20 percent of cancer patients and is one of ...
    ... Reportlinker.com announces that a new market research report is ... http://www.reportlinker.com/p091893/US-Enzymes-Market.html US ... in the US is forecast to rise more than five ... in recent years has been founded upon advances in higher-value, ...
    Cached Medicine Technology:Improvement in Prediction of Blood Clots in Cancer Patients 2Improvement in Prediction of Blood Clots in Cancer Patients 3Reportlinker Adds US Enzymes Market 2Reportlinker Adds US Enzymes Market 3Reportlinker Adds US Enzymes Market 4Reportlinker Adds US Enzymes Market 5Reportlinker Adds US Enzymes Market 6Reportlinker Adds US Enzymes Market 7Reportlinker Adds US Enzymes Market 8
    (Date:7/29/2015)... ... July 29, 2015 , ... According to The Spirits Business ... is directly responsible for stimulating and perpetuating alcohol use disorders. Humans have the same ... of the National academy of Sciences, and has given researchers inklings to explore Rsu1 ...
    (Date:7/29/2015)... ... July 29, 2015 , ... CrossFit 269, offering a nationally ... Kalamazoo Strength & Conditioning. , The name change coincides with the release of ... training center over the past three years,” according to Jack Kelly, the center’s ...
    (Date:7/29/2015)... ... July 29, 2015 , ... For the second year in ... in the list of the 50 fastest growing companies in Jacksonville. This annual list ... community. On July 16th, a team of Vast Bridges staffers were on hand to ...
    (Date:7/29/2015)... NY (PRWEB) , ... July 29, 2015 , ... CanAm ... approved by USCIS over the past month! I-829 approvals have been granted to investors ... Los Angeles, the Kimpton Lafayette Hotel project in Philadelphia, and the Valley Forge ...
    (Date:7/29/2015)... ... July 29, 2015 , ... A June 10, 2015 article from the News-Press, ... the importance of having regular skin cancer screenings from an early age. Skin cancer ... rays. When caught early, skin cancer is rarely fatal; however, if left alone for ...
    Breaking Medicine News(10 mins):Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 2Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 3Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 2Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 3Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 4Health News:Vast Bridges Continues Its Swift Growth 2Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 2Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 3Health News:Get Checked for Skin Cancer Early and Often 2Health News:Get Checked for Skin Cancer Early and Often 3
    ... Tampa, FL (Feb. 27, 2008) -- The cancer-related protein Akt ... forms bundles of tangled nerve cell fibers in the brain ... researchers at the University of South Florida and the Mayo ... online Feb. 21 in the early edition of the Proceedings ...
    ... Inc. (Nasdaq: MAPP ) today announced financial results ... The net loss for the fourth quarter and ... million, respectively, compared with $8.5,million and $25.8 million during ... equivalents and short-term investments as of,December 31, 2007 of ...
    ... Feb. 28 Mansfield ISD,s Ben Barber,Career and Technology ... of,a new Student Minor Procedures Laboratory, funded with a ... will ensure health,occupation students at Ben Barber get a ... simulates scenarios students would face if employed in a,physician,s ...
    ... Taps International Icon for Global Marketing Campaign and Cause-Related ... ... THE REUTER,S WNS FEED AT 4:05 ... Amway Corporation announced today,that it has signed two-time FIFA Player of the ...
    ... 28 Ten prominent journalists from the United States ... fourth annual TempletonCambridge Journalism Fellowships in Science & Religion. ... fellowships include a program of research and scholarship at ... fellows were announced today by the New York office ...
    ... Project, (http://www.thehealingproject.org ) is launching today Voices Who ... with,life-threatening or chronic illnesses. This website is designed ... individuals with a forum,where they can meet online., ... online tool in our,arsenal of interpersonal communication and ...
    Cached Medicine News:Health News:MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results 2Health News:MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results 3Health News:MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results 4Health News:MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results 5Health News:MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results 6Health News:MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results 7Health News:Ben Barber Career Tech Academy Leaps Forward With Help From Methodist Mansfield 2Health News:International Soccer Superstar Ronaldinho Signs With Nutrilite(TM) 2Health News:International Soccer Superstar Ronaldinho Signs With Nutrilite(TM) 3Health News:International Soccer Superstar Ronaldinho Signs With Nutrilite(TM) 4Health News:4th annual Templeton-Cambridge fellowships awarded to 10 noted journalists 2Health News:4th annual Templeton-Cambridge fellowships awarded to 10 noted journalists 3Health News:4th annual Templeton-Cambridge fellowships awarded to 10 noted journalists 4Health News:New Social Networking Website Connects Patients and Caregivers 2
    Designed as an excellent form of primary suspension...
    ... T.E.O.™ was designed to meet the constant ... traveling kit provides all components necessary to ... Pair 1002-A4 Aluminum pre-contoured adjustable knee joints ... , 2 Unique adjustable thigh bands , ...
    ... controlled compression and cold, the Calf Cryo/Cuff ... designed cuff provides complete calf coverage for ... a single cuff, or with a cooler ... The Cooler is available separately and can ...
    ... designed to comfortably restrict motion of ... motion of the fingers and wrist. ... splint may be trimmed using cast ... gun. One cotton stockinet is included ...
    Medicine Products: